Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
11.3M
-
Shares change
-
+11.3M
-
Total reported value, excl. options
-
$249M
-
Value change
-
+$249M
-
Put/Call ratio
-
0.67
-
Number of buys
-
44
-
Price
-
$22.36
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q4 2015
51 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q4 2015.
NovoCure Ltd - Common Stock (NVCR) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.3M shares
of 112M outstanding shares and own 10.1% of the company stock.
Largest 10 shareholders include FMR LLC (5.18M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.59M shares), HIGHLINE CAPITAL MANAGEMENT, L.P. (1.42M shares), MORGAN STANLEY (430K shares), ALKEON CAPITAL MANAGEMENT LLC (375K shares), Rock Springs Capital Management LP (214K shares), BlackRock Fund Advisors (207K shares), Century Capital Management, LLC (133K shares), STATE STREET CORP (87.2K shares), and NORGES BANK (75K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.